Back to search

Ireland· IE-PA-PA2219/011/001

FIBRYGA, 1 g, powder and solvent for solution for injection/infusion

A fibrinogen, human product containing human fibrinogen, registered in Ireland by Octapharma (IP). The same ATC class is registered in 11 of our 19 countries.

ATC B02BB01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedFIBRYGA, 1 g, powder and solvent for …ATCB02BB01REGISTER NO.IE-PA-PA2219/011/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Fibrinogen, human is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BB01 (fibrinogen, human), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Fibrinogen, human · ATC B02BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fibrinogen, human costs, country by country.

Normalised to the WHO defined daily dose (5 g), the median price runs from $2.30 in Czechia to $2694.05 in Switzerland — a ×1171 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Fibrinogen, human · price per daily dose (5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2694.05
  • CZ Czechia$2.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Human fibrinogen
Manufacturer
Octapharma (IP)
Country
Ireland (IE)
ATC code
B02BB01
ATC class
Fibrinogen, human
Defined daily dose
5 g, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2219/011/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for fibrinogen, human.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fibrinogen, human · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fibrinogen, human in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fibrinogen, human products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Fibclot, Fibryga
  • Belgium · Fibclot, Fibryga
  • Bulgaria · Fibryga, Хемокомплетан P
  • Cyprus · Fibryga, Riastap
  • Czechia · Fibryga, Haemocomplettan P
  • Germany · Fibclot, Fibryga
  • Denmark · Fibclot, Fibryga
  • Estonia · Fibryga
  • Spain · Fibclot, Fibryga
  • Finland · Fibclot, Fibryga
  • France · Clottafact, Fibryga
  • United Kingdom (Northern Ireland) · Fibclot, Fibryga
  • Greece · Fibclot, Riastap
  • Croatia · Fibryga
  • Hungary · Fibclot, Fibryga
  • Iceland · Fibryga, Riastap
  • Italy · Fibriclotte, Fibryga
  • Lithuania · Fibryga
  • Luxembourg · Fibclot, Fibryga
  • Latvia · Fibryga
  • Malta · Fibryga, Riastap
  • Netherlands · Fibclot, Fibryga
  • Norway · Fibclot, Fibryga
  • Poland · Fibryga, Riastap
  • Portugal · Fibryga, Haemocomplettan
  • Romania · Fibryga, Haemocomplettan P
  • Sweden · Fibclot, Fibryga
  • Slovenia · Fibrema, Prufibry
  • Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7cb8ed60-45ab-44b9-8e5a-200ddd832f50
GET /v1/drugs/7cb8ed60-45ab-44b9-8e5a-200ddd832f50?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection/infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B02BB01"
  ],
  "strength": null,
  "pa_number": "PA2219/011/001",
  "substances": [
    "Human fibrinogen"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "04/09/2020",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about fibrinogen, human.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.